All Stories

  1. Morbidity and mortality in patients with rheumatoid arthritis compared with an age- and sex-matched control population: A nationwide register study
  2. A review of sleep research in patients with spinal cord injury
  3. Sleep quality and circadian rhythm disruption in the intensive care unit: a review
  4. A Sleep Position Trainer for positional sleep apnea: a randomized, controlled trial
  5. Melatonin Secretion Pattern in Critically Ill Patients: A Pilot Descriptive Study
  6. Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development
  7. Subjective sleep quality and daytime sleepiness in late midlife and their association with age-related changes in cognition
  8. Sleep stability and transitions in patients with idiopathic REM sleep behavior disorder and patients with Parkinson’s disease
  9. Melatonin and cortisol profiles in late midlife and their association with age-related changes in cognition
  10. Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset
  11. Inter-expert and intra-expert reliability in sleep spindle scoring
  12. A validation of wrist actigraphy against polysomnography in patients with schizophrenia or bipolar disorder
  13. Onset of impaired sleep as a predictor of change in health-related behaviours; analysing observational data as a series of non-randomized pseudo-trials
  14. Physical activity and the association with fatigue and sleep in Danish patients with rheumatoid arthritis
  15. HLA-DPB1 and HLA Class I Confer Risk of and Protection from Narcolepsy
  16. Analysis of automated quantification of motor activity in REM sleep behaviour disorder
  17. Einfluss nächtlicher Hypoglykämien auf den Schlaf bei Menschen mit Typ 2 Diabetes
  18. All-cause mortality from obstructive sleep apnea in male and female patients with and without continuous positive airway pressure treatment: a registry study with 10 years of follow-up
  19. Blunted autonomic response in cluster headache patients
  20. The economic burden of Tuberculosis in Denmark 1998-2010. Cost analysis in patients and their spouses
  21. EIF3G is associated with narcolepsy across ethnicities
  22. Heart rate response during sleep in elderly patients after fast-track hip and knee arthroplasty
  23. Sleep quality and correlates of poor sleep in patients with rheumatoid arthritis
  24. The efficacy of motivational counseling and SMS-reminders on daily sitting time in patients with rheumatoid arthritis: protocol for a randomized controlled trial
  25. Automated differentiation between epileptic and nonepileptic convulsive seizures
  26. Sleep and chronobiology in cluster headache
  27. Automatic Real-Time Embedded QRS Complex Detection for a Novel Patch-Type Electrocardiogram Recorder
  28. HLA-DPB1 and HLA Class I Confer Risk of and Protection from Narcolepsy
  29. Sleep in cluster headache − beyond a temporal rapid eye movement relationship?
  30. Erratum to: Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case–control study
  31. Reduced CSF hypocretin-1 levels are associated with cluster headache
  32. Impaired sleep and allostatic load: cross-sectional results from the Danish Copenhagen Aging and Midlife Biobank
  33. miRNA profiles in cerebrospinal fluid from patients with central hypersomnias
  34. A Comprehensive Study of Extended Tetrathiafulvalene Cruciform Molecules for Molecular Electronics: Synthesis and Electrical Transport Measurements
  35. Health, Social and Economic Consequences of Polyneuropathy: A Controlled National Study Evaluating Societal Effects on Patients and Their Partners
  36. Increased all-cause mortality with psychotropic medication in Parkinson's disease and controls: A national register-based study
  37. Does autoreactivity have a role in narcolepsy?
  38. OP5 THE IMPACT OF NOCTURNAL HYPOGLYCAEMIA ON SLEEP IN SUBJECTS WITH TYPE 2 DIABETES
  39. Early Automatic Detection of Parkinsonʼs Disease Based on Sleep Recordings
  40. HLA DQB1*06:02 Negative Narcolepsy with Hypocretin/Orexin Deficiency
  41. Sleep–Wake Transition in Narcolepsy and Healthy Controls Using a Support Vector Machine
  42. EHMTI-0150. A controlled study of sleep in cluster headache patients.apo04
  43. EHMTI-0149. Low CSF hypocretin-1 levels are associated with cluster headache
  44. miRNA Profiles in Plasma from Patients with Sleep Disorders Reveal Dysregulation of miRNAs in Narcolepsy and Other Central Hypersomnias
  45. Automatic sleep classification using a data-driven topic model reveals latent sleep states
  46. Data-driven modeling of sleep EEG and EOG reveals characteristics indicative of pre-Parkinson's and Parkinson's disease
  47. Novel method for detection of Sleep Apnoea using respiration signals
  48. Detection of K-complexes based on the wavelet transform
  49. Automatic quality classification of entire electrocardiographic recordings obtained with a novel patch type recorder
  50. Sleep Problems and Daily Functioning in Children With ADHD: An Investigation of the Role of Impairment, ADHD Presentations, and Psychiatric Comorbidity
  51. Quantitative analysis of surface electromyography during epileptic and nonepileptic convulsive seizures
  52. P409: Automatic MSLT sleep/wake detection using novelty feature scaling
  53. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination
  54. P1045: Automatic sleep classification using a data-driven approach reveals six latent sleep states
  55. P201: Late midlife sleep pattern and sleep structure and the association to age-related changes in cognition
  56. P1056: Secondary narcolepsy with intermediate hypocretin level due to brain tumour – a case story
  57. P97: Frontal lobe epilepsy versus NREM sleep parasomnia: clinical and EEG characteristics
  58. P1046: Data-driven modeling of sleep EEG and EOG reveals stages indicative of pre-Parkinson and Parkinson’s disease
  59. P296: Sensorimotor gating deficits in multiple system atrophy: comparison with Parkinson’s disease and idiopathic REM sleep behavior disorder
  60. P482: Reliable monitoring of respiration rate with reflectance-mode photoplethysmography
  61. O36: Sleep spindle scoring: performance of humans versus machines
  62. P203: Subjective sleep quality and daytime sleepiness in late midlife and the association to age-related changes in cognition
  63. P295: Increased motor activity during REM sleep is linked with dopamine-function in idiopathic REM sleep behaviour disorder and Parkinson’s disease
  64. Sleep Impairment and Prognosis of Acute Myocardial Infarction: A Prospective Cohort Study
  65. The sensory construction of dreams and nightmare frequency in congenitally blind and late blind individuals
  66. Morbidity in early Parkinson's disease and prior to diagnosis
  67. Epidemiology of sleep apnea/hypopnea syndrome and sleep-disordered breathing
  68. Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case–control study
  69. Sleep-wake and melatonin pattern in craniopharyngioma patients
  70. Postoperative Sleep Disturbances after Zolpidem Treatment in Fast-Track Hip and Knee Replacement
  71. Decreased sleep spindle density in patients with idiopathic REM sleep behavior disorder and patients with Parkinson’s disease
  72. Sensorimotor gating deficits in multiple system atrophy: Comparison with Parkinson's disease and idiopathic REM sleep behavior disorder
  73. Sleep-spindle detection: crowdsourcing and evaluating performance of experts, non-experts and automated methods
  74. Effect of intermittent aerobic exercise on sleep quality and sleep disturbances in patients with rheumatoid arthritis – design of a randomized controlled trial
  75. Comorbidity and medication in REM sleep behavior disorder: A multicenter case-control study
  76. Sleep Disturbances After Fast-Track Hip and Knee Arthroplasty
  77. Rapid Eye Movement Sleep Behavior Disorder as an Outlier Detection Problem
  78. Direct and indirect economic and health consequences of COPD in Denmark: a national register-based study: 1998–2010
  79. The Incidence of Late-Onset Pompe Disease in Subjects with Obstructive Sleep Apnea: A Cross-Sectional Study
  80. Corrigendum to “Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group” [S...
  81. Economic and Health Consequences of COPD Patients and Their Spouses in Denmark—1998–2010
  82. Parkinsonism as an outlier detection problem
  83. Mortality of obesity hypoventilation with and without CPAP Treatment : a controlled national study
  84. Morbidity and mortality in children with obstructive sleep apnea: a controlled national study
  85. Usage of psychotropic medication in obstructive sleep apnea: a controlled national study
  86. EIF3G is associated to narcolepsy
  87. Age-related changes in sleep pattern and sleep structure and the association to cognitive performance: the metropolit 1953 danish male birth cohort
  88. Increased motor activity during rem sleep is linked with dopamine function in idiopathic rem sleep behaviour disorder and Parkinson’s disease
  89. All-cause mortality of sleep apnoea with and without CPAP treatment in male and female patients: A controlled national study
  90. miRNA profiling in plasma from patients with sleep disorders reveals dysregulation of miRNAs in narcolepsy and other central hypersomnias
  91. Reduced sympathetic activity in idiopathic rapid-eye-movement sleep behavior disorder and Parkinson's disease
  92. Design and Synthesis of Organic Molecules for Molecular Electronics
  93. Corrigendum to “Health, social, and economic consequences of narcolepsy: a controlled national study evaluating the societal effect on patients and their partners” [Sleep Med 13/8 (2012) 1086–1093]
  94. Physical activity maintenance in patients with rheumatoid arthritis: a qualitative study
  95. Activity, Sleep and Cognition After Fast-Track Hip or Knee Arthroplasty
  96. Sleep Transitions in Hypocretin-Deficient Narcolepsy
  97. Morbidities in rapid eye movement sleep behavior disorder
  98. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy
  99. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group
  100. Acute Sleep Restriction Reduces Insulin Sensitivity in Adolescent Boys
  101. Detection of a sleep disorder predicting Parkinson's disease
  102. SLEEP phenomena as an early biomarker for Parkinsonism
  103. Automatic SLEEP staging: From young aduslts to elderly patients using multi-class support vector machine
  104. Classification of iRBD and Parkinson's disease patients based on eye movements during sleep
  105. Classification of iRBD and Parkinson's patients using a general data-driven sleep staging model built on EEG
  106. Health, social and economic consequences of hypersomnia: a controlled national study from a national registry evaluating the societal effect on patients and their partners
  107. Morbidity and mortality in children with obstructive sleep apnoea: a controlled national study
  108. Comorbidity and Mortality of Narcolepsy: A Controlled Retro- and Prospective National Study
  109. Increased serum brain-derived neurotrophic factor (BDNF) levels in patients with narcolepsy
  110. OP0102-HPR Sedentary Behaviour in Danish Patients with Rheumatoid Arthritis - What is the Association to Pain, Fatigue, Sleep and Physical Function? A Cross-Sectional Study
  111. Family history of idiopathic REM behavior disorder: A multicenter case-control study
  112. Low-frequency oscillations and vasoreactivity of cortical vessels in obstructive sleep apnea during wakefulness: A near infrared spectroscopy study
  113. Narcolepsy and pregnancy: a retrospective European evaluation of 249 pregnancies
  114. Social consequences of sleep disordered breathing on patients and their partners: a controlled national study
  115. Listening to music for improving sleep in adults with insomnia
  116. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study
  117. The characterization of sleep--wake pattern and its association with melatonin, as a marker of the circadian function of the suprachiasmatic nucleus, in craniopharyngioma patients
  118. Health, Social, and Economic Consequences of Neck Injuries
  119. Dynamics of muscle activation during tonic–clonic seizures
  120. Characteristics of rapid eye movement sleep behavior disorder in narcolepsy
  121. Morbidity prior to a Diagnosis of Sleep-Disordered Breathing: A Controlled National Study
  122. ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy
  123. The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns
  124. Hypocretin Deficiency Develops During Onset of Human Narcolepsy with Cataplexy
  125. Attenuated Heart Rate Response is Associated with Hypocretin Deficiency in Patients with Narcolepsy
  126. Manipulation of organic polyradicals in a single-molecule transistor
  127. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society
  128. Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study
  129. Treatment options for residual insomnia in schizophrenia
  130. Obstructive Sleep Apnea in a Danish Population of Men and Women Aged 60-80 Years with Nocturia
  131. Detection of hypoglycemia associated EEG changes during sleep in type 1 diabetes mellitus
  132. Health, social, and economic consequences of narcolepsy: A controlled national study evaluating the societal effect on patients and their partners
  133. Predictors of Hypocretin (Orexin) Deficiency in Narcolepsy Without Cataplexy
  134. A New Class of Extended Tetrathiafulvalene Cruciform Molecules for Molecular Electronics with Dithiafulvene-4,5-Dithiolate Anchoring Groups
  135. Automatic detection of REM sleep in subjects without atonia
  136. Evaluation of novel algorithm embedded in a wearable sEMG device for seizure detection
  137. Separation of Parkinson's patients in early and mature stages from control subjects using one EOG channel
  138. Validation of a novel automatic sleep spindle detector with high performance during sleep in middle aged subjects
  139. Sleep disturbances after fast-track hip and knee arthroplasty
  140. The socioeconomic consequences of optic neuritis with and without multiple sclerosis: a controlled national study
  141. Sleep restriction is not associated with a positive energy balance in adolescent boys
  142. Chronic pain and sleep disorders
  143. Environmental risk factors for REM sleep behavior disorder: A multicenter case-control study
  144. Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency
  145. A single-question screen for rapid eye movement sleep behavior disorder: A multicenter validation study
  146. Attenuated heart rate response in REM sleep behavior disorder and Parkinson's disease
  147. Health, Social And Economical Consequences Of Chronic Obstructive Pulmonary Disease (COPD): A Controlled National Study
  148. Cluster headache and sleep, is there a connection? A review
  149. Sleep disturbances in critically ill patients in ICU: how much do we know?
  150. Corrigendum to “Cost of disorders of the brain in Europe 2010” [Eur. Neuropsychopharmacol. 21 (2011) 718–779]
  151. Molecular Junctions Based on SAMs of Cruciform Oligo(phenylene ethynylene)s
  152. A Computerized Algorithm for Arousal Detection in Healthy Adults and Patients With Parkinson Disease
  153. The socioeconomic consequences of multiple sclerosis: A controlled national study
  154. Standard procedures for adults in accredited sleep medicine centres in Europe
  155. Insomnia in central neurologic diseases – Occurrence and management
  156. Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol
  157. Cost of disorders of the brain in Europe 2010
  158. Erratum: Common variants in P2RY11 are associated with narcolepsy
  159. Sleep Disorders in Neurodegenerative Disorders and Stroke
  160. M-N-126 RETROSPECTIVE EVALUATION OF PREGNANCIES IN EUROPEAN NARCOLEPTICWOMEN
  161. The size and burden of mental disorders and other disorders of the brain in Europe 2010
  162. Automatic REM sleep detection associated with idiopathic rem sleep Behavior Disorder
  163. Detection of arousals in Parkinson's disease patients
  164. Changes in cerebral glucose metabolism in early symptomatic frontotemporal dementia linked to chromosome 3 (FTD-3)
  165. Clinical presentation and mutations in Danish patients with Wilson disease
  166. Erratum: Corrigendum: Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy
  167. The health-related, social, and economic consequences of parkinsonism: a controlled national study
  168. The social and economic consequences of epilepsy: A controlled national study
  169. Health, social and economical consequences of sleep-disordered breathing: a controlled national study
  170. Synthesis of Oligo(phenyleneethynylene)s with Vertically Disposed Tetrathiafulvalene Units
  171. Common variants in P2RY11 are associated with narcolepsy
  172. P9-1 Multi-modal REM behaviour disorder detection associated with neurodegenerative diseases
  173. P22-21 PPI of the acoustic startle response is associated with visual processing and executive function in idiopathic RBD and Parkinson's disease
  174. P9-8 Validation of manual and automatic sleep scoring in normals and patients with neurodegenerative disorders
  175. P9-10 REM sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency
  176. P9-11 Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population
  177. Intravenous Immunoglobulin Treatment and Screening for Hypocretin Neuron-Specific Autoantibodies in Recent Onset Childhood Narcolepsy with Cataplexy
  178. Sleep Disorders in Neurodegenerative Disorders and Stroke
  179. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy
  180. REM Behaviour Disorder detection associated with neurodegenerative diseases
  181. Automatic Sleep Scoring in Normals and in Individuals With Neurodegenerative Disorders According to New International Sleep Scoring Criteria
  182. The socio-economical burden of hypersomnia
  183. Anal sphincter EMG in the diagnosis of parkinsonian syndromes
  184. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency
  185. Sodium oxybate is an effective and safe treatment for narcolepsy
  186. Quality of life, co-morbidity and obstructive sleep apnoea
  187. Sleep disordered breathing following spinal cord injury
  188. Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing
  189. Language function following subdural grid-directed temporal lobectomy
  190. Outcome of resective surgery for intractable partial epilepsy guided by subdural electrode arrays
  191. Effect of barbiturate on epileptiform activity: comparison between intravenous and oral administration
  192. Nocturia and associated morbidity in a Danish population of men and women aged 60-80 years
  193. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis
  194. Medico-legal implications of sleep apnoea syndrome: Driving license regulations in Europe
  195. Rapid Eye Movement Sleep Disturbances in Huntington Disease
  196. Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea–hypopnoea syndrome
  197. Report of an EFNS task force on management of sleep disorders in neurologic disease (degenerative neurologic disorders and stroke)
  198. Pathophysiological Aspects of Nocturia in a Danish Population of Men and Women Age 60 to 80 Years
  199. Double-blind crossover trial of gabapentin in SPG4-linked hereditary spastic paraplegia
  200. Antibodies in narcolepsy???cataplexy patient serum bind to rat hypocretin neurons
  201. Prevalence and bother of nocturia, and causes of sleep interruption in a Danish population of men and women aged 60–80 years
  202. Validity and Reliability of a Questionnaire for Evaluating Nocturia, Nocturnal Enuresis and Sleep-Interruptions in an Elderly Population
  203. Spontaneous Epileptic Rats Show Changes in Sleep Architecture and Hypothalamic Pathology
  204. Measurement of cortical and hippocampal epileptiform activity in freely moving rats by means of implantable radiotelemetry
  205. Motor evoked potentials from the striated urethral sphincter and puborectal muscle: reproducibility of latencies
  206. Motor evoked potentials from the striated urethral sphincter and puborectal muscle: Normative values
  207. Motor evoked potentials from the striated urethral sphincter: A comparison of concentric needle and surface electrodes
  208. Sleep and nocturia
  209. The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society
  210. Sleep and headache
  211. EEG measurements by means of radiotelemetry after intracerebroventricular (ICV) cannulation in rodents
  212. The standardisation of terminology in nocturia: Report from the standardisation sub-committee of the International Continence Society
  213. The effect of oral desmopressin (Minirin®) on sleep in male and female patients with nocturia
  214. Short-term reproducibility of cystometry and pressure-flow micturition studies in healthy women
  215. Motor evoked potentials from the external anal sphincter in patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p
  216. Nocturia in women
  217. Increased intracortical facilitation in patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p
  218. A computer-based information system for epilepsy and electroencephalography
  219. Autosomal dominant pure spastic paraplegia: a clinical, paraclinical, and genetic study
  220. A prospective study of 39 patients with whiplash injury
  221. P420 Repetitive magnetic stimulations of the rat
  222. Snoring and atherosclerotic manifestations in a 70-year-old population
  223. Repetitive transcranial magnetic stimulations of the rat effect of acute and chronic stimulations on pentylenetetrazole-induced clonic seizures
  224. Snoring and Headache: An Important Association-Reply
  225. Risk of Ischemic Heart Disease in Self-reported Snorers
  226. Snoring, Family History, and Genetic Markers in Men
  227. Repetitive magnetic stimulation and motor evoked potentials
  228. Headache and Cognitive Dysfunctions in Snorers
  229. EEG changes following repetitive transcranial magnetic stimulation in patients with temporal lobe epilepsy
  230. Transcranial magnetic stimulation. Its role in the evaluation of patients with partial epilepsy
  231. Speech localization using repetitive transcranial magnetic stimulation
  232. Self-Assessed Cognitive Function in Snorers and Sleep Apneics
  233. Snoring and Risk of Stroke and Ischaemic Heart Disease in a 70 Year Old Population. A 6-Year Follow-up Study
  234. Self-Reported Sleep Disturbances and Daytime Complaints in Women with Fibromyalgia and Rheumatoid Arthritis
  235. Snoring, sympathetic activity and cardiovascular risk factors in a 70 year old population
  236. Speech localization using transcranial repetitive magnetic stimulation. A new diagnostic tool in the evaluation of patients with epilepsy
  237. Repetitive magnetic stimulation of the cortex and a peripheral nerve
  238. Snoring, Sleep Apnoea and Cardiovascular Risk Factors: The MONICA II Study
  239. Alpha Intrusion in Fibromyalgia
  240. PATHOLOGY OF SKELETAL MUSCLE IN FIBROMYALGIA: A HISTO-IMMUNO-CHEMICAL AND ULTRASTRUCTURAL STUDY
  241. Epidemiology of snoring and obstructive sleep apnoea in a Danish population, age 30-60
  242. Cardiovascular risk factors in snorers. A cross-sectional study of 3,323 men aged 54 to 74 years: the Copenhagen Male Study.
  243. Compound motor action potentials generated by repetitive magnetic stimulation
  244. Compound Motor Action Potentials Generated By Repetitive Magnetic Stimulation
  245. An epidemiological study of REM latency and psychiatric disorders
  246. Zopiclone in the Treatment of Sleep Abnormalities in Fibromyalgia
  247. Blood Pressure, Catecholamines, and Pancreatic Polypeptide in Obstructive Sleep Apnea With and Without Nasal Continuous Positive Airway Pressure (nCPAP) Treatment
  248. Intracranial Pressure and Obstructive Sleep Apnea
  249. White lead exposure among Danish police officers employed in fingerprint detection.
  250. Adaptive Segmentation Of EEG Signals
  251. Sleep Disorders in Neurologic Disease